As of April 2024 Zoetis has a market cap of $72.38 Billion. This makes Zoetis the world's 239th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $72.38 B | -20.11% |
2023 | $90.61 B | 32.67% |
2022 | $68.30 B | -40.84% |
2021 | $115.45 B | 46.79% |
2020 | $78.65 B | 24.98% |
2019 | $62.93 B | 53.42% |
2018 | $41.02 B | 16.86% |
2017 | $35.10 B | 32.8% |
2016 | $26.43 B | 10.91% |
2015 | $23.83 B | 10.49% |
2014 | $21.57 B | 31.98% |
2013 | $16.34 B |
On Apr 28th, 2024 the market cap of Zoetis was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $143.82 B | 98.69% | ๐บ๐ธ USA |
Eli Lilly LLY | $697.39 B | 863.39% | ๐บ๐ธ USA |
Sanofi SNY | $122.65 B | 69.43% | ๐ซ๐ท France |
Merck MRK | $332.33 B | 359.09% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | $0.51 B | -99.29% | ๐บ๐ธ USA |
Kindred Biosciences
KIN | $0.42 B | -99.42% | ๐บ๐ธ USA |
Heska Corporation
HSKA | $1.30 B | -98.19% | ๐บ๐ธ USA |